April 7, 2010:
May 26, 2015:
October 27, 2015:
FDA approves first-of-its-kind product for the treatment of melanoma
Skin cancer is the most common form of cancer in the United States. Melanoma, one type of skin cancer, is the leading cause of skin cancer related deaths, and is most often caused by exposure to ultraviolet (UV) light. According to the National Cancer Institute approximately 74,000 Americans will be diagnosed with melanoma and nearly 10,000 will die from the disease in 2015.
Imlygic, a genetically modified live oncolytic herpes virus therapy, is used to treat melanoma lesions that cannot be removed completely by surgery. Imlygic is injected directly into the melanoma lesions, where it replicates inside cancer cells and causes the cells to rupture and die.
WHOOOOHOOO!!!!!
*highfivesallaround*
Some older videos I just found interesting:
- Log in to post comments
More like this
Sweet! Go HSV-1! Do something useful for once!